Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36495464)

  • 1. Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines.
    Marques V; Ourô S; Afonso MB; Rodrigues CMP
    J Physiol Biochem; 2023 May; 79(2):261-272. PubMed ID: 36495464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.
    Buijsen J; van Stiphout RG; Menheere PP; Lammering G; Lambin P
    Radiother Oncol; 2014 May; 111(2):237-42. PubMed ID: 24746569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.
    Sung S; Son SH; Kay CS; Lee YS
    Medicine (Baltimore); 2016 Mar; 95(10):e2965. PubMed ID: 26962798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
    Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
    Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
    Huang D; Lin Q; Song J; Xu B
    Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
    Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
    Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
    Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer.
    Yang J; Ling X; Tang W; Hu D; Zhou H; Yin G
    J BUON; 2019; 24(1):77-83. PubMed ID: 30941954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.
    Chung MJ; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
    Int J Colorectal Dis; 2016 Sep; 31(9):1595-601. PubMed ID: 27464635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
    Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Akiyoshi T; Tanaka N; Kiyotani K; Gotoh O; Yamamoto N; Oba K; Fukunaga Y; Ueno M; Mori S
    Br J Surg; 2019 Sep; 106(10):1381-1392. PubMed ID: 31197828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.
    Li A; He K; Guo D; Liu C; Wang D; Mu X; Yu J
    Future Oncol; 2019 Oct; 15(28):3233-3242. PubMed ID: 31373223
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response.
    Bowden DL; Sutton PA; Wall MA; Jithesh PV; Jenkins RE; Palmer DH; Goldring CE; Parsons JL; Park BK; Kitteringham NR; Vimalachandran D
    J Proteomics; 2018 May; 179():53-60. PubMed ID: 29518574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.